Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on September 8, 2026

43 minutes ago

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

43 minutes ago

QualTex Laboratories adds ISO/IEC 17025 accreditation for microbiology in San Antonio, Atlanta

Indeterminate GlobeNewswire

43 minutes ago

Collegium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

43 minutes ago

Walden Biosciences to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

43 minutes ago

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

43 minutes ago

Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program

Indeterminate GlobeNewswire

43 minutes ago

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

43 minutes ago

Flare Therapeutics Appoints Peter Lebowitz, MD, PhD, to Board of Directors and Brian DeSchuytner as Chief Financial Officer and Chief Business Officer

Indeterminate GlobeNewswire

43 minutes ago

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

43 minutes ago

MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Indeterminate GlobeNewswire

43 minutes ago

Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring® Implant and Delivery System Procedures

Indeterminate GlobeNewswire

43 minutes ago

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire

43 minutes ago

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

43 minutes ago

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

Indeterminate GlobeNewswire

43 minutes ago

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

43 minutes ago

AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group

Indeterminate GlobeNewswire

43 minutes ago

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire

43 minutes ago

Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET

Indeterminate GlobeNewswire

43 minutes ago

Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

43 minutes ago

Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure

Indeterminate GlobeNewswire